Phospho-Hexokinase 1 (Tyr732) Antibody - #AF3709
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF3709, RRID:AB_2847023.
折りたたみ/展開
BB404130; Brain form hexokinase; dea; DrHXK1; EC 2.7.1.1; Glycolytic enzyme; HEXOKIN; hexokinase I; Hexokinase PI; Hexokinase type I; Hexokinase, tumor isozyme; Hexokinase-1; Hexokinase-A; HK I; HK1; HK1 tb; Hk1-s; HK1-ta; HK1-tb; HK1-tc; HKD; HKI; HMSNR; HXK1; HXK1_HUMAN; im:7148527; mHk1-s; wu:fc09d08; wu:fc16e02; wu:fc21e02; wu:fq14b11; zgc:55790; zgc:77618;
免疫原
A synthesized peptide derived from human Hexokinase 1 around the phosphorylation site of Tyr732.
Isoform 2: Erythrocyte specific (Ref.6). Isoform 3: Testis-specific (PubMed:10978502). Isoform 4: Testis-specific (PubMed:10978502).
- P19367 HXK1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTATVKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVHGSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGVEGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYMEELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGMYLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLGVEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVDGSLYKTHPQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLTKDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRVLLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGFTFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVGTMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDDIRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRGIFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAAVVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKGAALITAVGVRLRTEASS
PTMs - P19367 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
Y25 | Phosphorylation | Uniprot | |
Y27 | Phosphorylation | Uniprot | |
K62 | Ubiquitination | Uniprot | |
K77 | Acetylation | Uniprot | |
S124 | Phosphorylation | Uniprot | |
K147 | Ubiquitination | Uniprot | |
S155 | Phosphorylation | Uniprot | |
K173 | Ubiquitination | Uniprot | |
K176 | Methylation | Uniprot | |
K176 | Ubiquitination | Uniprot | |
S178 | Phosphorylation | Uniprot | |
K187 | Ubiquitination | Uniprot | |
K191 | Ubiquitination | Uniprot | |
S269 | Phosphorylation | Uniprot | |
K290 | Ubiquitination | Uniprot | |
S298 | Phosphorylation | Uniprot | |
Y301 | Phosphorylation | Uniprot | |
K315 | Ubiquitination | Uniprot | |
K333 | Ubiquitination | Uniprot | |
S337 | Phosphorylation | Uniprot | |
S340 | Phosphorylation | Uniprot | |
K344 | Ubiquitination | Uniprot | |
K346 | Ubiquitination | Uniprot | |
S364 | Phosphorylation | Uniprot | |
T403 | Phosphorylation | Uniprot | |
Y417 | Phosphorylation | Uniprot | |
K418 | Ubiquitination | Uniprot | |
T419 | Phosphorylation | Uniprot | |
Y461 | Phosphorylation | Uniprot | |
K489 | Acetylation | Uniprot | |
K501 | Ubiquitination | Uniprot | |
T503 | Phosphorylation | Uniprot | |
K510 | Ubiquitination | Uniprot | |
K544 | Acetylation | Uniprot | |
K624 | Ubiquitination | Uniprot | |
Y686 | Phosphorylation | Uniprot | |
R727 | Methylation | Uniprot | |
Y732 | Phosphorylation | P12931 (SRC) | Uniprot |
S733 | Phosphorylation | Uniprot | |
K738 | Ubiquitination | Uniprot | |
Y749 | Phosphorylation | Uniprot | |
K763 | Acetylation | Uniprot | |
K763 | Ubiquitination | Uniprot | |
K777 | Ubiquitination | Uniprot | |
S792 | Phosphorylation | Uniprot | |
C813 | S-Nitrosylation | Uniprot | |
T821 | Phosphorylation | Uniprot | |
C823 | S-Nitrosylation | Uniprot | |
S827 | Phosphorylation | Uniprot | |
R849 | Methylation | Uniprot | |
K880 | Ubiquitination | Uniprot | |
K885 | Ubiquitination | Uniprot | |
S893 | Phosphorylation | Uniprot | |
T913 | Phosphorylation | Uniprot |
研究背景
Catalyzes the phosphorylation of various hexoses, such as D-glucose, D-glucosamine, D-fructose, D-mannose and 2-deoxy-D-glucose, to hexose 6-phosphate (D-glucose 6-phosphate, D-glucosamine 6-phosphate, D-fructose 6-phosphate, D-mannose 6-phosphate and 2-deoxy-D-glucose 6-phosphate, respectively). Does not phosphorylate N-acetyl-D-glucosamine. Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate (By similarity). Involved in innate immunity and inflammation by acting as a pattern recognition receptor for bacterial peptidoglycan. When released in the cytosol, N-acetyl-D-glucosamine component of bacterial peptidoglycan inhibits the hexokinase activity of HK1 and causes its dissociation from mitochondrial outer membrane, thereby activating the NLRP3 inflammasome.
Mitochondrion outer membrane>Peripheral membrane protein. Cytoplasm>Cytosol.
Note: The mitochondrial-binding peptide (MBP) region promotes association with the mitochondrial outer membrane (Probable). Dissociates from the mitochondrial outer membrane following inhibition by N-acetyl-D-glucosamine, leading to relocation to the cytosol (PubMed:27374331).
Isoform 2: Erythrocyte specific (Ref.6). Isoform 3: Testis-specific. Isoform 4: Testis-specific.
Monomer. Interacts with RABL2/RABL2A; binds preferentially to GTP-bound RABL2 (By similarity). Interacts with VDAC1. The HK1-VDAC1 complex interacts with ATF2. Interacts (via N-terminal spermatogenic cell-specific region) with PFKM (via C-terminus) (By similarity).
The N- and C-terminal halves of this hexokinase contain a hexokinase domain (PubMed:9493266, PubMed:9735292, PubMed:10574795). The catalytic activity is associated with the C-terminus while regulatory function is associated with the N-terminus (PubMed:9493266, PubMed:9735292, PubMed:10574795). Each domain can bind a single D-glucose and D-glucose 6-phosphate molecule (PubMed:9493266).
Belongs to the hexokinase family.
研究領域
· Environmental Information Processing > Signal transduction > HIF-1 signaling pathway. (View pathway)
· Human Diseases > Endocrine and metabolic diseases > Type II diabetes mellitus.
· Human Diseases > Cancers: Overview > Central carbon metabolism in cancer. (View pathway)
· Metabolism > Carbohydrate metabolism > Glycolysis / Gluconeogenesis.
· Metabolism > Carbohydrate metabolism > Fructose and mannose metabolism.
· Metabolism > Carbohydrate metabolism > Galactose metabolism.
· Metabolism > Carbohydrate metabolism > Starch and sucrose metabolism.
· Metabolism > Carbohydrate metabolism > Amino sugar and nucleotide sugar metabolism.
· Metabolism > Biosynthesis of other secondary metabolites > Neomycin, kanamycin and gentamicin biosynthesis.
· Metabolism > Global and overview maps > Metabolic pathways.
· Metabolism > Global and overview maps > Carbon metabolism.
· Organismal Systems > Endocrine system > Insulin signaling pathway. (View pathway)
· Organismal Systems > Digestive system > Carbohydrate digestion and absorption.
参考文献
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.